SCHEMBL24392846

SCHEMBL24392846

C=CC(=O)Nc1ccc(F)c(Nc2nc(Nc3cnn(C)c3)ncc2-c2cncc(Cl)c2)c1

nearest known ligand 0.61

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ JAK3 P52333 8/20 0.61
▸ JAK2 O60674 3/20 0.53
▸ JAK1 P23458 3/20 0.53
▸ TTK P33981 2/20 0.53
▸ MAP3K7 O43318 6/20 0.51
▸ MAPK1 P28482 2/20 0.51
▸ MAP2K1 Q02750 2/20 0.51
▸ BTK Q06187 2/20 0.49
▸ EGFR P00533 5/20 0.45
▸ FGFR1 P11362 4/20 0.45
▸ SRC P12931 4/20 0.45
▸ ITK Q08881 1/20 0.45
▸ TYK2 P29597 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29537472 1.00 JAK3 (0.61) JAK3JAK2JAK1TTKMAP3K7
SCHEMBL24388347 0.94 JAK3 (0.63) JAK3JAK2JAK1TTKMAP3K7
SCHEMBL29508102 0.94 JAK3 (0.63) JAK3JAK2JAK1TTKMAP3K7
SCHEMBL29538195 0.93 JAK3 (0.56) JAK3JAK2JAK1TTKMAP3K7
SCHEMBL24392840 0.93 JAK3 (0.56) JAK3JAK2JAK1TTKMAP3K7
SCHEMBL24392851 0.92 JAK3 (0.55) JAK3JAK2JAK1TTKMAP3K7
SCHEMBL29537303 0.92 JAK3 (0.55) JAK3JAK2JAK1TTKMAP3K7
SCHEMBL24392944 0.92 JAK3 (0.56) JAK3JAK2JAK1TTKMAP3K7
SCHEMBL24392741 0.92 JAK3 (0.60) JAK3JAK2JAK1TTKMAP3K7
SCHEMBL29537613 0.92 JAK3 (0.60) JAK3JAK2JAK1TTKMAP3K7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116685583-A Pyrimidine compounds, compositions and pharmaceutical uses thereof 缆图药品公司 2023-09-01 — — CN disclosed
WO-2022094354-A1 PYRIMIDINE COMPOUNDS, COMPOSITIONS, AND MEDICINAL APPLICATIONS THEREOF LENGO THERAPEUTICS, INC. (US) 2022-05-05 — — WO disclosed
Send feedback